Avantis takes $1.4M to diagnose colon cancer

Avantis Medical Systems, a biotech company that makes a device used to detect colon cancer, has brought in $1.4 million of an anticipated $4 million round of debt, rights and securities, according to a filing with the SEC. Based in Sunnyvale Calif., it is backed by BioStar Private Equity Fund, MedFocus Fund, Mitsubishi and Montreux Equity Partners.

Next Story: Obama to name cybersecurity chief to combat online attacks
Previous Story: Stealth-mode health care co. Zipline runs up $1M